25 years of ADME/DMPK/DDI service & product expertise
Trusted by 98% of top pharmas as well as numerous other organizations, Sekisui XenoTech is a global Contract Research Organization with unparalleled experience in ADME/DMPK/DDI research services and test systems. For the past 25 years, the company has offered proven expertise from discovery through clinical support, providing an ever-evolving selection of cell and tissue-based products, screening, radiolabeling, API manufacturing, in vitro ADMET and pharmacology, in vivo ADMET and QWBA, metabolite ID and production, bioanalytical services and consulting. Sekisui XenoTech's product selection includes a wide range of high-quality unique and standard reagents, including subcellular fractions, hepatocytes, tissue samples, cell lines, recombinant enzymes, substrates, metabolites and more. The company also regularly prepares and delivers custom-designed products and services in response to client requests. Visit www.xenotech.com to learn more.